Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy ...

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

Targeting KMA seeks to spare normal immunoglobulin-producing plasma cells, differentiating from BCMA-directed CAR T ...

Targeted extended circulation LNP achieved complete B cell depletion in nonhuman primates through highly specific in vivo CD8+ T cell engineering ...

In a phase 1 study, anti-CD7 chimeric antigen receptor (CAR) T cells induced complete remission in children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), with 82% ...

CAR T-cell therapy is considered a milestone in personalized cancer treatment. In this approach, a patient's own immune cells ...

CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand ...

It’s been more than four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the fast-moving world of cell therapies. When the Swiss pharma unveiled the ...

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is giving a ...

CAR-T therapies have transformed outcomes for several difficult-to-treat blood cancers globally. But despite strong initial responses, relapse remains one of the field’s biggest limitations.

Patty said that for caregivers, it’s essential to lean on the care team for information specific to the procedure, medication ...